These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11327663)

  • 21. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
    N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent.
    Aguayo-Carreras P; Cuenca-Barrales C; Perez-López I; Ruiz-Villaverde R; Tercedor-Sanchez J
    Int J Dermatol; 2019 Jul; 58(7):e137-e138. PubMed ID: 30883705
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion.
    Berman J; Dietze R
    Chemotherapy; 1999 Jun; 45 Suppl 1():54-66. PubMed ID: 10394022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for treatment of leishmaniasis in dogs.
    Oliva G; Roura X; Crotti A; Maroli M; Castagnaro M; Gradoni L; Lubas G; Paltrinieri S; Zatelli A; Zini E
    J Am Vet Med Assoc; 2010 Jun; 236(11):1192-8. PubMed ID: 20513197
    [No Abstract]   [Full Text] [Related]  

  • 25. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).
    Rabi Das VN; Siddiqui NA; Pal B; Lal CS; Verma N; Kumar A; Verma RB; Kumar D; Das P; Pandey K
    PLoS One; 2017; 12(3):e0174497. PubMed ID: 28355259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal amphotericin B.
    Sundar S
    Lancet; 2001 Mar; 357(9258):801-2. PubMed ID: 11253992
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse urinary effects of allopurinol in dogs with leishmaniasis.
    Torres M; Pastor J; Roura X; Tabar MD; Espada Y; Font A; Balasch J; Planellas M
    J Small Anim Pract; 2016 Jun; 57(6):299-304. PubMed ID: 27112522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.
    Sundar S; Chakravarty J; Rai VK; Agrawal N; Singh SP; Chauhan V; Murray HW
    Clin Infect Dis; 2007 Sep; 45(5):556-61. PubMed ID: 17682988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on the diagnosis and management of Leishmania spp infections in dogs in the United States.
    Freeman K
    Top Companion Anim Med; 2010 Aug; 25(3):149-54. PubMed ID: 20937498
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy for visceral leishmaniasis.
    van Griensven J; Boelaert M
    Lancet; 2011 Feb; 377(9764):443-4. PubMed ID: 21255829
    [No Abstract]   [Full Text] [Related]  

  • 31. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
    João A; Pereira MA; Cortes S; Santos-Gomes GM
    J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New World leishmaniasis from Spain.
    Tomson N; Symonds RP; Moir AA; Kendall CH; Wiselka MJ
    Postgrad Med J; 2002 Dec; 78(926):757-8. PubMed ID: 12509697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
    Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
    Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B.
    Malik R; Craig AJ; Wigney DI; Martin P; Love DN
    Aust Vet J; 1996 Apr; 73(4):124-8. PubMed ID: 8660225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visceral leishmaniasis mimicking systemic lupus erythematosus.
    Arlet JB; Capron L; Pouchot J
    J Clin Rheumatol; 2010 Jun; 16(4):203-4. PubMed ID: 20511988
    [No Abstract]   [Full Text] [Related]  

  • 36. Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
    Sundar S; Chakravarty J; Agarwal D; Rai M; Murray HW
    N Engl J Med; 2010 Feb; 362(6):504-12. PubMed ID: 20147716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on therapy and prevention of canine leishmaniasis.
    Apostolopoulos N; Mitropoulou A; Thom N; Moritz A
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):315-322. PubMed ID: 30541172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
    [No Abstract]   [Full Text] [Related]  

  • 39. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome).
    Davidson RN; di Martino L; Gradoni L; Giacchino R; Gaeta GB; Pempinello R; Scotti S; Cascio A; Castagnola E; Maisto A; Gramiccia M; di Caprio D; Wilkinson RJ; Bryceson AD
    Clin Infect Dis; 1996 Jun; 22(6):938-43. PubMed ID: 8783690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
    Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
    Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.